1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow MeRho-Az compound: new trials by email Literature Review of MeRho-Az compound trials Research Report on MeRho-Az compound
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Inflammatory Agent in Sinusitis AZ compound, Collection of Biological Specimens, Intranasal corticosteroid - Nasal Polyps | Phase 2 | Completed | Northwestern University | 43 | 2016-06-20 | 2022-05-25 |
| Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) AZ compound, Placebo - Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) | Phase 2 | Terminated | University of Alabama at Birmingham | 93 | 2015-11-01 | 2024-03-01 |
Nasal Polyps (1) · Non-alcoholic Fatty Liver Disease (1)
Northwestern University (1) · University of Alabama at Birmingham (1)
United States (1)
Anju T Peters, MD (1) · Rita Basu, MD (1)